People · Operator
Named in public records as an officer, director or promoter · active 2013–2018 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| MicroBiome Therapeutics, LLC | — | Other Health Care | Seed | $3.1M | $18.4M | 2013 |
| Scioto Biosciences, Inc. | — | Biotechnology | Seed | $1.8M | $80.9M | 2018 |
Mark Heiman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Heiman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Elstrott | 1 | 6 |
| Ross Barrett | 1 | 5 |
| Steve Orndorff | 1 | 3 |
| James Schulz | 1 | 3 |
| Dale Pfost | 1 | 3 |
| John B. Elstrott | 1 | 2 |
| Dean P. Stull | 1 | 2 |
| Richard B. Montgomery | 1 | 1 |
| Donald B. Marvin | 1 | 1 |
| Ross R. Barrett | 1 | 1 |
| Dale R. Pfost | 1 | 1 |
| Don Marvin | 1 | 1 |
| Richard Montgomery | 1 | 1 |
| Paul Cordes | 1 | 1 |
| Joseph Trebley | 1 | 1 |
| Kevin Meyer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.